Korro Bio, Inc.$46.74 %
Analyst Rating: Hold
Stock Details
CEO
Ram Aiyar MBA,
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
112
Address
One Kendall Square, Cambridge, MA, 02139-1562
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Top Competitors
Income Statement
Financials
Selected Year